Details for 2015000994

Up to date per 02.04.2026

Actions

Title / Product Name

VERWENDUNG VON ZELLDURCHLÄSSIGEN PEPTIDHEMMERN DES JNK-SIGNALTRANSDUKTIONSWEGES ZUR BEHANDLUNG VERSCHIEDENER KRANKHEITEN

Status

Deleted

Protection Type

European Patent

(AT-) Application Number

2015000994

EP Publication Number

2985031

E-Number

883180

Language

PCT Number

Publication Date

17.02.2016 A

12.04.2017 B1

Registration Date

12.04.2017

AT Publication Date

15.05.2017

Application Date

02.06.2009

Registration Number

Priorities

30.05.2008

PCT/EP2008/004341

IPC

A61K 38/01 20060101AFI20151117BHEP

Maximum Duration of Protection

02.06.2029

Owner

Xigen Inflammation Ltd.Arch. Makariou III 195 Neocleous House 3030 LimassolCY

Representative

No representatives present

Inventor

Bonny, ChristopheEn vernaules 1580 AvenchesCH